These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 15623986

  • 41. Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein.
    Akiyama H, Mohamedali KA, E Silva RL, Kachi S, Shen J, Hatara C, Umeda N, Hackett SF, Aslam S, Krause M, Lai H, Rosenblum MG, Campochiaro PA.
    Mol Pharmacol; 2005 Dec; 68(6):1543-50. PubMed ID: 16150930
    [Abstract] [Full Text] [Related]

  • 42. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
    Yamada K, Sakurai E, Itaya M, Yamasaki S, Ogura Y.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681
    [Abstract] [Full Text] [Related]

  • 44. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.
    Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1679-85. PubMed ID: 18385091
    [Abstract] [Full Text] [Related]

  • 45. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
    Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD.
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
    [Abstract] [Full Text] [Related]

  • 46. Octreotide inhibits choroidal neovascularization in rats.
    Qu Y, Zhang S, Xu X, Wang H, Li J, Zhou F, Wei F.
    Ophthalmic Res; 2009 May; 42(1):36-42. PubMed ID: 19478539
    [Abstract] [Full Text] [Related]

  • 47. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
    Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC.
    J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
    [Abstract] [Full Text] [Related]

  • 48. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M, Yang Y, Yan M, Zhang J.
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [Abstract] [Full Text] [Related]

  • 49. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ.
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [Abstract] [Full Text] [Related]

  • 50. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
    Zhao M, Shi X, Liang J, Miao Y, Xie W, Zhang Y, Li X.
    Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
    [Abstract] [Full Text] [Related]

  • 51. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F, Roscilli G, Lamartina S, Anderson KD, Bonelli F, Spence SG, Ciliberto G, Vogt TF, Holder DJ, Toniatti C, Thut CJ.
    Mol Vis; 2005 May 27; 11():366-73. PubMed ID: 15951738
    [Abstract] [Full Text] [Related]

  • 52. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
    Kusari J, Padillo E, Zhou SX, Bai Y, Wang J, Song Z, Zhu M, Le YZ, Gil DW.
    Invest Ophthalmol Vis Sci; 2011 Jul 20; 52(8):5424-31. PubMed ID: 21482645
    [Abstract] [Full Text] [Related]

  • 53. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y, Liang S, Yu W, Zhao M, Huang L, Zhao M, Li X.
    Mol Vis; 2014 Jul 20; 20():1258-70. PubMed ID: 25352735
    [Abstract] [Full Text] [Related]

  • 54. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
    Recalde S, Zarranz-Ventura J, Fernández-Robredo P, García-Gómez PJ, Salinas-Alamán A, Borrás-Cuesta F, Dotor J, García-Layana A.
    Invest Ophthalmol Vis Sci; 2011 Sep 09; 52(10):7090-7. PubMed ID: 21810978
    [Abstract] [Full Text] [Related]

  • 55. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K, Saishin Y, Saishin Y, Silva RL, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M, Connelly S, Luo T, Campochiaro PA.
    FASEB J; 2003 May 09; 17(8):896-8. PubMed ID: 12670875
    [Abstract] [Full Text] [Related]

  • 56. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y.
    Curr Eye Res; 2008 Oct 09; 33(10):892-902. PubMed ID: 18853324
    [Abstract] [Full Text] [Related]

  • 57. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S, Suh W.
    Mol Vis; 2017 Oct 09; 23():823-831. PubMed ID: 29225458
    [Abstract] [Full Text] [Related]

  • 58. VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
    Antes R, Salomon-Zimri S, Beck SC, Garcia Garrido M, Livnat T, Maharshak I, Kadar T, Seeliger M, Weinberger D, Michaelson DM.
    Curr Alzheimer Res; 2015 Oct 09; 12(4):323-34. PubMed ID: 25817253
    [Abstract] [Full Text] [Related]

  • 59. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
    Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N.
    Invest Ophthalmol Vis Sci; 2017 Jan 01; 58(1):299-308. PubMed ID: 28114591
    [Abstract] [Full Text] [Related]

  • 60. Angiostatic effect of CXCR3 expressed on choroidal neovascularization.
    Fujimura S, Takahashi H, Yuda K, Ueta T, Iriyama A, Inoue T, Kaburaki T, Tamaki Y, Matsushima K, Yanagi Y.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1999-2006. PubMed ID: 22408007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.